Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Completed

Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

NCT01518413

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumors, +25 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Children's Hospital Boston/Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

NCT00082758

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Central California Madera, California, United States
View all 81 locations
View Trial Details
Completed

iCAT for Recurrent/Refractory/HR Solid Tumors

NCT01853345

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, +29 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

NCT00357500

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumor, Pediatric, Hematologic Diseases, +23 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Maine Medical Center Research Institute Scarborough, Maine, United States
View Trial Details
Completed

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

NCT00311584

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 128 locations
View Trial Details

Related conditions